Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > New London Times article "Victory Against Rip-Off Drug Firms
View:
Post by CookieMonster on Sep 16, 2016 9:27am

New London Times article "Victory Against Rip-Off Drug Firms

https://www.thetimes.co.uk/article/victory-against-rip-off-drug-firms-after-times-investigation-qm6hlmqts
Comment by greatplay on Sep 16, 2016 9:32am
Again negative things in the industry are brought up.... Yes, stock isn't valued $100 USD anymore, all of these issues that brought stock down from $100 USD are being played out, but it's definitely worth more than $20 USD, not to say current $6 USD
Comment by greatplay on Sep 16, 2016 9:32am
Again negative things in the industry are brought up.... Yes, stock isn@t valued $100 USD anymore, all of these issues that brought stock down from $100 USD are being played out, but it@s definitely worth more than $20 USD, not to say current $6 USD
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities